The results showed that the expression levels of ALKBH1/2/8 were significantly up-regulated and the expression levels of ALKBH5/6/FTO were significantly down-regulated in GBM compared with normal tissues (Figure 2A). The gene discussed is ALKBH5; the disease is glioblastoma.